More than 18 million Americans with a history of invasive cancer were alive on January 1, 2022 (American Cancer Society). Navigating cancer involves navigating complex care needs, as 90% of patients experience cancer-related symptoms and nearly a third face emergency room visits within the first six months of chemotherapy. In this landscape, where both personal well-being and healthcare economics are at stake, the development and integration of innovative symptom management tools are crucial.
Oleena® contributes to improve adherence by empowering patients to self manage symptoms, using evidence-based algorithms to enhance the quality of life, treatment exposure, and ultimately increase survival.
Oleena is cleared for usage in the United States and obtained clearance by the FDA in 2019
Oleena provides the answer to “what should I do and when” by delivering real-time, personalized recommendations every time a patient reports a symptom. Patients are guided and supported according to their individual needs.
Through the Oleena interface, providers have access to automated and adaptative insights on their patients’ symptoms. Oleena triages the center’s patient population according to symptom severity, so providers know where to focus their attention.
When offering Oleena, practices invest beyond symptom monitoring. They empower timely and informed interventions to enhance quality of care, improve clinical outcomes and reduce costs.
"*" indicates required fields
* to process your contact request. If you do not fill them in, your request cannot be processed. To find out more about the use of your personal data and how to exercise your rights, please consult the Privacy Policy
